Integrating Genome Sequencing in Health Care Systems: Evaluation, Implementation, and Population Health Impact



Co-Sponsors

  • Precision Medicine and Population Health Interest Group, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health
  • Center for Translation Research and Implementation Science, National Heart, Lung and Blood Institute, National Institutes of Health
  • Office of Public Health Genomics, Centers for Disease Control and Prevention

February 14, 2018, 2:00-3:00 pm EST
NCI Shady Grove Campus, Room 2E032/034

FREE REGISTER REQUIRED: REGISTER NOW

Human genome sequencing is increasingly used in a variety of health systems in the United States and globally. Clinical screening programs share the goal of examining genes or variants in unselected populations to identify individuals at increased risk to help prevent future disease, or adverse drug outcomes. Many current genomic-based screening programs examine germline variability in specific genes that have been evaluated and recommended by evidence groups. Others are implementing whole genome or whole exome sequencing as part of biobank efforts linked with electronic health records and/or other epidemiologic data.

  • Presentations. Each presenter will review current experiences; and evidentiary, economic, data sharing and infrastructure, and outcome data requirements needed to implement and measure success of genome sequencing in improving health. (20 minutes each; 40 minutes total)
  • Discussion and Q&As. Emphasis is on how the presented information should inform an implementation science agenda in genomic medicine. (20 minutes)

Integrating Genomics into Large Health Systems: Challenges in Implementation and Evaluation

W. GREGORY FEERO

GREGORY FEERO, MD, PhD
Faculty, Maine Dartmouth Family Medicine Residency Program, Augusta, Maine
Associate Editor for Genomics, the Journal of the American Medical Association

Recent Relevant Publications:

Integrating Genomics into Large Health Systems: The Geisinger Experience

 

MICHAEL MURRAY

MICHAEL MURRAY, MD
Director of Clinical Genomics, Geisinger Health System
Danville, Pennsylvania

 

Recent Relevant Publications:

Page last reviewed: January 2, 2018 (archived document)